SEC Form 4 · accession 0001567619-18-002466
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arnold L Oronsky
Director
Period of report
Sep 10, 2018
Accepted (ET)
Sep 12, 2018 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 10, 2018 | P | 58,824 | $17.00 | A | 388,766 | I | InterWest Partners IX, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares held by InterWest Partners IX, L.P. is a California limited partnership ("InterWest"), whose general partner is InterWest Management Partners IX, LLC, a California limited liability company. Dr. Oronsky, one of the Company's directors, currently serves as a Managing Director of InterWest. Each managing director and venture member of InterWest Management Partners IX, LLC shares voting and investment power with respect to the securities held by InterWest and disclaims beneficial ownership of such shares except to the extent of his or her pecuniary interest therein.